Trans Chromosomics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 1

Trans Chromosomics General Information

Description

Provider of medical research and development services of pharmaceutical products. The company's services include researching on antibody drug seeds, drug development and toxicity, chromosome analysis, cell production and pharmaceutical seeds using chromosome engineering technology,

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3F Odenmacho Ichiban Building
  • 2-1 Nihonbashi Odenmacho, Chuo-ku
  • Tokyo, 103-0011
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 3F Odenmacho Ichiban Building
  • 2-1 Nihonbashi Odenmacho, Chuo-ku
  • Tokyo, 103-0011
  • Japan
+81

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trans Chromosomics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Trans Chromosomics‘s full profile, request access.

Request a free trial

Trans Chromosomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trans Chromosomics FAQs

  • When was Trans Chromosomics founded?

    Trans Chromosomics was founded in 2014.

  • Where is Trans Chromosomics headquartered?

    Trans Chromosomics is headquartered in Tokyo, Japan.

  • What is the size of Trans Chromosomics?

    Trans Chromosomics has 18 total employees.

  • What industry is Trans Chromosomics in?

    Trans Chromosomics’s primary industry is Drug Discovery.

  • Is Trans Chromosomics a private or public company?

    Trans Chromosomics is a Private company.

  • What is Trans Chromosomics’s current revenue?

    The current revenue for Trans Chromosomics is .

  • How much funding has Trans Chromosomics raised over time?

    Trans Chromosomics has raised $1.32M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »